COVID-19 Respiratory Infection — Study of the Use of the Drug Ingaron in Patients With COVID-19
Citation(s)
Prospective Two-week Open-label Application Experimental Randomized Single-center Non-interventional Study of the Drug Ingaron in Patients With a New Coronavirus Infection COVID-19